KLOW – TB-500 10mg / BPC-157 10mg / KPV 10mg / GHK-Cu 50mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of KLOW Peptide Blend supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques. Batch: Refer to COA documentation Key analytical results include:

• Peptide Component Assay Verification: confirmed
• Identification – Retention Time: verified for each peptide component
• Purity: greater than 99 percent for peptide fractions
• Bacterial Endotoxins: below laboratory reporting limits
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

KLOW Peptide Blend is a multi-peptide research formulation studied in laboratory environments investigating peptide signalling networks, cellular regulatory pathways and peptide interaction systems. The formulation combines several synthetic peptides commonly used in experimental models exploring intracellular signalling mechanisms and peptide-mediated biochemical regulation. This preparation contains 80 mg of high purity lyophilized peptide complex supplied in a sealed research vial. Lyophilization preserves peptide structural stability and allows researchers to reconstitute the preparation for controlled in vitro experimentation. Because the formulation contains multiple peptide signalling compounds, KLOW Peptide Blend is frequently examined in experimental models investigating complex peptide interaction networks.

Compound Overview

KLOW Peptide Blend is composed of several laboratory-grade peptides that interact with different biological signalling pathways. Each peptide component may influence separate receptor systems or intracellular signalling mechanisms, allowing researchers to study complex regulatory interactions between peptide molecules. In biochemical research models, multi-peptide formulations allow scientists to investigate how signalling molecules interact within cellular communication networks. These peptide signalling systems are frequently examined in experimental research exploring intracellular regulatory pathways and receptor-mediated biochemical processes.

Historical Background and Scientific Context

Research into synthetic peptides expanded significantly during the late twentieth century as peptide synthesis technologies improved. Scientists began investigating how individual peptide molecules interact with cellular receptors and signalling systems. As peptide research progressed, multi-peptide experimental formulations were developed to allow researchers to study complex interactions between signalling molecules. These formulations are now widely used in laboratory research investigating peptide-mediated regulatory systems and cellular signalling pathways.

Mechanistic Focus in Research

Within experimental laboratory environments, KLOW Peptide Blend is often studied in relation to peptide-mediated signalling networks. Research investigations commonly explore the formulation in experimental models examining:

• Multi-peptide signalling pathways
• Peptide receptor interaction dynamics
• Cellular regulatory signalling networks
• Intracellular peptide communication systems
• Comparative peptide interaction research
• Peptide-mediated biochemical regulation
• Complex cellular signalling pathway modelling

These experimental models allow scientists to investigate molecular mechanisms that influence peptide signalling networks and intracellular regulatory systems.

Research Applications

In controlled research environments, KLOW Peptide Blend may be utilised in experimental models designed to explore peptide interaction systems and cellular signalling networks. Examples of research applications include:

• Peptide signalling pathway investigation
• Multi-peptide interaction studies
• Cellular signalling network analysis
• Intracellular regulatory pathway modelling
• Comparative peptide compound evaluation
• Biochemical signalling research
• Controlled in vitro peptide interaction studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation. Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Includes BPC-157, GHK-Cu, KPV and TB-500 in defined assay ratios
• Purity and identity independently validated for all components
• Endotoxin level below 0.01 EU per mg
• No detectable heavy metals or microbial contamination
• Batch GF092025044 – Published November 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.